These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 11990078

  • 1. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates.
    Nowak P, Brus R, Kostrzewa RM.
    Pol J Pharmacol; 2001; 53(4):319-29. PubMed ID: 11990078
    [Abstract] [Full Text] [Related]

  • 2. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum.
    Nowak P, Dabrowska J, Bortel A, Izabela B, Kostrzewa RM, Brus R.
    Neurotoxicol Teratol; 2006; 28(5):563-72. PubMed ID: 17005368
    [Abstract] [Full Text] [Related]

  • 3. DSP-4 prevents dopamine receptor priming by quinpirole.
    Nowak P, Labus Ł, Kostrzewa RM, Brus R.
    Pharmacol Biochem Behav; 2006 May; 84(1):3-7. PubMed ID: 16675001
    [Abstract] [Full Text] [Related]

  • 4. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole.
    Brown RW, Perna MK, Schaefer TL, Williams MT.
    Synapse; 2006 Apr; 59(5):253-9. PubMed ID: 16408261
    [Abstract] [Full Text] [Related]

  • 5. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
    Koeltzow TE, Austin JD, Vezina P.
    Neuropharmacology; 2003 Jan; 44(1):102-10. PubMed ID: 12559127
    [Abstract] [Full Text] [Related]

  • 6. Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity.
    Perna MK, Brown RW.
    Behav Brain Res; 2013 Apr 01; 242():102-9. PubMed ID: 23291224
    [Abstract] [Full Text] [Related]

  • 7. 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study.
    Nowak P, Brus R, Oświecimska J, Sokoła A, Kostrzewa RM.
    J Physiol Pharmacol; 2002 Jun 01; 53(2):251-63. PubMed ID: 12120900
    [Abstract] [Full Text] [Related]

  • 8. Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.
    Cope ZA, Huggins KN, Sheppard AB, Noel DM, Roane DS, Brown RW.
    Synapse; 2010 Apr 01; 64(4):289-300. PubMed ID: 19953655
    [Abstract] [Full Text] [Related]

  • 9. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
    Nowak P, Szczerbak G, Biedka I, Drosik M, Kostrzewa RM, Brus R.
    J Physiol Pharmacol; 2006 Dec 01; 57(4):583-97. PubMed ID: 17229983
    [Abstract] [Full Text] [Related]

  • 10. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
    Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW.
    Eur J Neurosci; 2007 Nov 01; 26(9):2532-8. PubMed ID: 17970732
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats.
    Brus R, Szkilnik R, Kostrzewa RM.
    Acta Neurobiol Exp (Wars); 1996 Nov 01; 56(1):15-9. PubMed ID: 8787167
    [Abstract] [Full Text] [Related]

  • 12. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P, Flore G, Pira L, Diana M, Gessa GL.
    Psychopharmacology (Berl); 2002 Mar 01; 160(2):220-4. PubMed ID: 11875641
    [Abstract] [Full Text] [Related]

  • 13. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB, Thompson AC, Shippenberg T.
    Synapse; 2001 Mar 15; 39(4):343-50. PubMed ID: 11169785
    [Abstract] [Full Text] [Related]

  • 14. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
    Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP.
    Neurotox Res; 2003 Mar 15; 5(5):329-38. PubMed ID: 14715452
    [Abstract] [Full Text] [Related]

  • 15. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models.
    Lv H, Li A, Ma H, Liu F, Xu H.
    J Ethnopharmacol; 2009 Jul 30; 124(3):488-92. PubMed ID: 19467315
    [Abstract] [Full Text] [Related]

  • 16. Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
    Dethy S, Laute MA, Damhaut P, Goldman S.
    J Neural Transm (Vienna); 1999 Jul 30; 106(2):145-58. PubMed ID: 10226935
    [Abstract] [Full Text] [Related]

  • 17. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ.
    Exp Neurol; 2005 Jun 30; 193(2):420-6. PubMed ID: 15869944
    [Abstract] [Full Text] [Related]

  • 18. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC.
    Neurochem Int; 2008 Jan 30; 52(1-2):119-29. PubMed ID: 17716783
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Apr 30; 245(1):199-210. PubMed ID: 3129549
    [Abstract] [Full Text] [Related]

  • 20. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
    Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR.
    J Pharmacol Exp Ther; 1993 Jan 30; 264(1):249-55. PubMed ID: 8093727
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.